[Chlamydia trachomatis in young conscripts--survey, urine analysis and urethral culture].
Explore the source record for details and available documents.
Biomedical subjects
Publications and source records attributed to H Gnarpe.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Subjectively healthy persons were investigated for the presence of Mycoplasma pneumoniae in throat cultures. During a peak period of M. pneumoniae incidence, 13.5% of 758 healthy volunteers were found to harbour the bacterium in the throat. The investigation was continued, and during a subsequent period of 11 months, the incidence of M. pneumoniae isolated decreased to 4.6% of 499 volunteers. All new blood donor sera 1990-1991 (422 sera) were screened for the presence of antibodies to M. pneumoniae; it was found that there was a fluctuating but significant number of individuals with positive serology based on a single test occasion.
Explore the source record for details and available documents.
Subjectively healthy persons were investigated for the presence of Chlamydia pneumoniae (TWAR) with throat cultures using the HL (human lung) cell line. C. pneumoniae was isolated from 11/234 investigated persons.
A total of 707 cultures for Chlamydia trachomatis were obtained from healthy teenage girls attending an adolescence clinic for family planning. Apart from sampling from the endocervix, specimens were also obtained from outside the squamocolumnar junction and from the posterior fornix and cultured separately in order to study whether it was possible to improve the detection rate of C trachomatis by sampling from outside the endocervix. In 91 (12.8%) of the girls a positive culture was found. Of the chlamydia positive samples, 83.5% were obtained from the endocervix and 95% from outside the squamocolumnar junction of the portio. Of the 91 positive cultures, 15 (16.5%) were positive only in the sample obtained from the portio surface. The results indicate that the detection rate of C trachomatis could be improved by extended specimen collection. C trachomatis was isolated significantly more often when there was an ectopy, irrespective of whether the specimens had been collected from the endocervix or from outside the squamocolumnar junction. C trachomatis was particularly common if there was an ectopy and a bleeding at specimen collection. If there was no bleeding at sampling, C trachomatis was equally common in women with as in those without an ectopy.
Explore the source record for details and available documents.
All patients referred for gastroscopy were investigated by Campylobacter pylori culture and antibody titration. An enzyme immunoassay was developed and found to have a negative predictive value of 0.997, which indicates that serologic tests could be used for screening of patients before gastroscopy. A close correlation was found between active and inactive duodenal and gastric ulcer and positive C. pylori culture. Small open treatment trials with the antibiotics doxycycline, tinidazole, amoxycillin, and norfloxacin were ineffective for the eradication of C. pylori. Treatment with the new anti-ulcer agents enprostil, rioprostil, and omeprazole had no effect on the presence of C. pylori.
This double-blind pilot study has been undertaken in order to investigate the effect of amoxicillin and pronounced suppression of gastric acid secretion on mucosal colonisation with Campylobacter pylori (CP). Twenty four CP-positive patients were included in the study and assigned to 14 days of treatment in either one of the following three therapy groups: Group 1: Omeprazole 40 mg o.m. + Amoxicillin 750 mg b.i.d (9 pat); Group 2: Omeprazole 40 mg o.m. (8 pat); Group 3: Amoxicillin 750 mg b.i.d (7 pat). Gastroscopy with biopsy for culture and histology was performed pre-entry, at cessation of therapy and four weeks later. In the group receiving omeprazole and amoxicillin in combination 5 out of 8 patients were negative for CP four weeks after stopping treatment, while in the amoxicillin and the omeprazole groups respectively one (1/7) and none (0/8) were negative. Except for one patient who was withdrawn because of severe diarrhoea, only minor adverse effects occurred.
In a clinical, controlled trial 55 women with a history of pelvic inflammatory disease (PID) undergoing first-trimester abortion were randomized to either lymecycline therapy or placebo. Twenty-four women received lymecycline capsules 300 mg b.i.d. for 14 days starting on the morning of the abortion and 31 received similar placebo medication. In the lymecycline group 2 women (8.3%) and in the placebo group 7 (22.6%) contracted postabortal PID, a non-significant difference (p greater than 0.2). The variables age, gestational age, number of spontaneous abortions, births and episodes of PID, and Hegar size were not associated with the rate of postabortal PID. Women without previous induced abortions had a significantly increased rate of postabortal infection (p = 0.02), but the treatment did not influence this rate. Three women had a positive culture for Chlamydia trachomatis at the time of abortion and two of these had postabortal PID. None of 7 women with postabortal PID had significant increases in IgA, IgG or IgM chlamydia antibody titers, but two women with uncomplicated abortions had serological evidence of infection. The number of hospital days and amounts of antibiotics prescribed to women with postabortal PID were not significantly different between the two treatment groups (p greater than 0.05). Women with a history of PID had an elevated risk of postabortal PID warranting the use of some sort of prophylaxis, and screening for C. trachomatis in an abortion population is recommended.
Cultures for Chlamydia trachomatis were obtained from 1012 teenage girls attending an adolescence clinic mainly for family planning; C. trachomatis was isolated from 174 (17.2%). The proportion of chlamydia-positive girls varied between 15.7% and 28.5% depending whether or not there were symptoms and signs of infection. Neither the history nor the finding at pelvic examination offered conclusive evidence for or against the presence of an infection with C. trachomatis. Of the chlamydia-positive, untreated, asymptomatic girls, 17.5% developed symptoms of a genital infection within 3 months. There was a statistically significant difference in the proportion of positive cultures by the two investigators, suggesting that the procedure for specimen collection is of great importance.
Campylobacter pylori was isolated more often from patient with peptic ulcers and in an age-related manner in a material of 395 consecutive patients referred for gastroscopy. Direct microscopy was done with Gram and Acridine Orange stain and found too insensitive for practical use. All patients were investigated serologically with an enzyme immunoassay which showed excellent correlation with positive cultures for C. pylori. The findings were discussed, and the enzyme immunoassay, with a negative predictive value of 0.99, was found to be a valuable tool for primary screening of patients suspected of being carriers of C. pylori.
Seven patients with active duodenal ulcer and positive cultures for Campylobacter pylori were given anti-ulcer treatment for 28 days with the addition of doxycycline for the last nine days. Repeated endoscopy with biopsy for culture and doxycycline concentration determinations from the mucosa at the end of doxycycline therapy showed that five of seven patients remained positive in culture. The concentrations of doxycycline in biopsy material were 0.1 to 0.3 mg/kg in four patients; in three patients the level of antibiotic was not measurable. The serum concentrations of doxycycline in six patients varied between 0.5 and 2.7 mg/l. One patient had less than 0.5 mg/l. The two patients with C. pylori negative cultures at the end of therapy had serum concentrations of doxycycline of 2.4 and 1.0 mg/l. These patients were positive in biopsy culture for C. pylori 12 weeks after therapy. In conclusion, doxycycline does not eradicate C. pylori when given in recommended dosage for 9 days.
Vaginal wet smear, endocervical swab test, gynecologic examination, and history were investigated in 148 healthy female adolescents. Cultures for Chlamydia trachomatis were obtained from all patients. The overall prevalence was 19/148 (13%). No significant correlation was found between chlamydia infection and any of the parameters investigated in the wet smear. Results of swab test or history showed no discrimination between young women with cultures positive for C. trachomatis and those with cultures negative for C. trachomatis. Chlamydia was found in 32% of patients when the gynecologic examination showed signs of infection and in 10% when no signs of infection were seen (p less than 0.025). Thirteen of the 19 (70%) adolescents with chlamydia infections had no signs of infection. We conclude that neither swab test, vaginal wet smear, nor the history of the patient can give conclusive evidence of a chlamydial infection. Detection of C. trachomatis in this population can be done only by culture or other specific methods.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Three acidic polysaccharide (AP) fractions and the prostaglandin-like substances (PLS) isolated from P. acnes were investigated regarding their chemotactic activities on polymorphonuclear leukocytes. Both AP's and PLS induced a significant chemotatic response, which suggests their involvement in inflammatory acne vulgaris.
Co-trimazine, a new preparation of sulphadiazine and trimethoprim, was compared with nitrofurantoin in a double-blind trial on patients with acute urinary tract infections. Co-trimazine had a bacteriological cure rate of 95% as compared to 88% for nitrofurantoin. There were no statistically significant differences in laboratory findings or in clinical side-effects between the two laboratory findings or in clinical side-effects between the two preparations. It was concluded that co-trimazine might constitute a valuable addition amongst drugs suitable for treatment of acute urinary tract infections.